Who is sponsoring NCT02389062?

NCT02389062 is sponsored by Thomas Jefferson University.

What condition does NCT02389062 study?

NCT02389062 studies Adult Form of Celiac Disease.

Is NCT02389062 still recruiting?

NCT02389062 is currently completed. Last updated 19 July 2019.

Last reviewed 2019-07-19 · How we verify

NCT02389062

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients

Completed NA Last updated 19 July 2019

What this trial tests

NA trial testing Administration of gluten( food /wheat protein) capsules or placebo(cornstarch) capsules and tests for novel markers will be done at intervals. in Adult Form of Celiac Disease in 5 participants. Completed in 11 February 2017.

Timeline

11 February 2015

Primary endpoint
11 February 2016

11 February 2017

Quick facts

Lead sponsor	Thomas Jefferson University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	quadruple
Primary purpose	diagnostic
Enrollment	5
Start date	11 February 2015
Primary completion	11 February 2016
Estimated completion	11 February 2017
Sites	1 location across United States

Drugs / interventions tested

Administration of gluten( food /wheat protein) capsules or placebo(cornstarch) capsules and tests for novel markers will be done at intervals.

Conditions studied

Adult Form of Celiac Disease — all drugs for Adult Form of Celiac Disease →

Sponsor

Thomas Jefferson University

Who can join

Adults 18 to 80, any sex, with Adult Form of Celiac Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a clinical trial to evaluate the sensitivity of noninvasive, novel markers of gluten ingestion in celiac disease patients who are following gluten free diet for at least a period of one year. These noninvasive markers may be helpful to monitor the silent intestinal damage, possibly resulting from the accidental consumption of gluten due to cross contamination of gluten free diet.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Thomas Jefferson University trials

Trials by the same sponsor.

NCT07526480 — Improving Dementia Care in Primary Practice · NA · not yet recruiting
NCT07414550 — Radiotherapy for Refractory Hidradenitis Suppurativa · NA · not yet recruiting
NCT07402018 — Intra-aortic Balloon Counterpulsation (IABC) Compliance · recruiting
NCT07217197 — Respiratory Monitoring System That Detects & Predicts OIRD · NA · enrolling by invitation
NCT07145099 — The IMPACT Study: Personalized Physical Therapy for Better Recovery and a Stronger Core After Hernia Surgery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02389062 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Thomas Jefferson University
Last refreshed: 19 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02389062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing